Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Gareth Veal

Newcastle AuthorsTitleYearFull text
Dr Pawan Gulati
Dr Vickyanne Carruthers
Dr Claire Hutton
Chloe Cassidy
Dr Edward Amankwatia
et al.		An assessment of circulating biomarkers and germline genetic variants in predicting chemotherapy associated mucositis in Ewing sarcoma2025
Dr Shelby Barnett
Professor Gareth Veal
Development and validation of a LC-MS/MS method for the quantification of novel therapeutic TT-478, a selective adenosine receptor 2B antagonist, for a phase I/II clinical trial2025
Professor Gareth Veal
Local application of sodium thiosulfate as an otoprotectant for cisplatin-exposed patients - a narrative literature review to explore the potential benefit for children with cancer2025
Professor Gareth Veal
Nutritional status, body composition and chemotherapy dosing in children and young people with cancer: a systematic review by the SIOP nutrition network2025
Dr Andrew Brandon
Dr Shelby Barnett
Professor Gareth Veal
Recommended approaches for integration of population pharmacokinetic modelling with precision dosing in clinical practice2025
Professor Gareth Veal
Understanding the potential importance of pharmacokinetic variability in the setting of ALL2025
Professor Gareth Veal
A phase I open-label, dose-escalation study of NUC-3373, a targeted thymidylate synthase inhibitor, in patients with advanced cancer (NuTide:301)2024
Dr Shelby Barnett
Professor Gareth Veal
A Population Pharmacokinetic Study to Evaluate Doxorubicin Exposure Across All Age Groups2024
Dr Hayden Bell
Dr Helen Blair
Samantha Jepson Gosling
Dr Martin Galler
Dan Astley
et al.		Combination p53 activation and BCL-xL/BCL-2 inhibition as a therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia2024
Professor Gareth Veal
Philip Berry
Neurosurgical application of olaparib from a thermo-responsive paste potentiates DNA damage to prolong survival in malignant glioma2024
Professor Gareth Veal
The use of sodium thiosulfate as an otoprotectant in cancer patients treated with platinum compounds: a review of the literature2024
Professor Gareth Veal
Dr Shelby Barnett
Utility of carboplatin therapeutic drug monitoring for the treatment of neonate and infant retinoblastoma patients in the United Kingdom2024
Professor Gareth Veal
A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer2023
Julieann Sludden
Professor Gareth Veal
Professor Ruth Plummer
A Phase 1/2A trial of idroxioleic acid: First-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma2023
Professor Gareth Veal
Professor Steve Wedge
Dr Christopher Bacon
Professor Philip Sloan
Professor Alastair Greystoke
et al.		A phase I dose-escalation study of AZD3965, an oral monocarboxylate transporter 1 inhibitor, in patients with advanced cancer2023
12345678910